Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in …

…, P Quartier, D Rosellini, F Alaoui, M De Bandt… - Annals of the …, 2008 - ard.bmj.com
Background: Anakinra treatment has been reported to be effective in some patients with
systemic-onset juvenile idiopathic arthritis (SoJIA) or adult-onset Still disease (AoSD). Objectives…

Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French autoimmunity and rituximab registry

…, P Cacoub, A Cantagrel, M De Bandt… - Arthritis & …, 2010 - Wiley Online Library
Objective A number of open‐label studies have suggested the potential benefit of rituximab (RTX)
in systemic lupus erythematosus (SLE). However, in 2 recent randomized controlled …

[HTML][HTML] Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

M De Bandt, J Sibilia, X Le Loët, S Prouzeau… - Arthritis research & …, 2005 - Springer
The development of drug-induced lupus remains a matter of concern in patients treated with
anti-tumour necrosis factor (TNF) alpha. The incidence of such adverse effects is unknown. …

Vasculitides induced by TNFα antagonists: a study in 39 patients in France

B Saint Marcoux, M De Bandt - Joint Bone Spine, 2006 - Elsevier
TNFα antagonists are effective in the treatment of chronic inflammatory joint disease.
Despite a good overall safety profile, they can induce a number of adverse effects, including …

Tocilizumab in refractory adult Still's disease

X Puéchal, M DeBandt, JM Berthelot… - Arthritis Care & …, 2011 - Wiley Online Library
Objective There is an unmet need for the treatment of adult Still's disease (ASD), the
pathogenesis of which may involve interleukin‐6 (IL‐6). We report the first series of patients with …

Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area

…, O Fain, R Dhote, Z Amoura, M De Bandt… - Arthritis care & …, 2014 - Wiley Online Library
Objective To describe the epidemiology of primary Sjögren's syndrome (SS) in a multiracial/multiethnic
population. Methods A cross‐sectional study with 5 case‐retrieval sources …

Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study

…, S Querellou, F Garrigues, M De Bandt… - Annals of the …, 2016 - ard.bmj.com
Background Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR)
but induce adverse events. Objectives To evaluate the efficacy and safety of first-line …

Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial

R Seror, G Baron, E Hachulla, M Debandt… - Annals of the …, 2014 - ard.bmj.com
Michel Debandt4, … Funding This study was sponsored by Assistance Publique-Hopitaux
de Paris and received an unrestricted research grant from Abbott. Abbott did not play any role in …

Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature

JM Berthelot, M De Bandt, P Goupille, E Solau-Gervais… - Joint Bone Spine, 2009 - Elsevier
OBJECTIVE: To report on the outcome of 15 cases of pregnancies in women treated with
anti-TNF drugs during conception or pregnancy METHODS: French rheumatologists …

A tool to identify recent or present rheumatoid arthritis flare from both patient and physician perspectives: the 'FLARE'instrument

JM Berthelot, M De Bandt, J Morel, F Benatig… - Annals of the …, 2012 - ard.bmj.com
Michel De Bandt2, … Information préalable au remplissage du questionnaire: Ce questionnaire
a été créé de telle manière qu'il peut soit être rempli par le patient seul, soit par le médecin …